Stockscreener 앱 받기
1.34
3.60%
-0.05
시간 외 거래:
1.34
전일 마감가:
$1.39
열려 있는:
$1.46
하루 거래량:
1.25M
Relative Volume:
7.00
시가총액:
$194.54M
수익:
$49.09M
순이익/손실:
$-52.15M
주가수익비율:
-1.2182
EPS:
-1.1
순현금흐름:
$-45.93M
1주 성능:
-18.79%
1개월 성능:
-20.71%
6개월 성능:
-4.29%
1년 성능:
-16.25%
1일 변동 폭
$1.33
$1.46
1주일 범위
$1.28
$1.7197
52주 변동 폭
$1.15
$2.21
바이오데식스 Stock (BDSX) Company Profile
명칭
Biodesix Inc
전화
303-417-0500
주소
919 WEST DILLON ROAD, LOUISVILLE
바이오데식스 Stock (BDSX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-11-17 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-11-23 | 개시 | BTIG Research | Buy |
| 2020-11-23 | 개시 | Canaccord Genuity | Buy |
| 2020-11-23 | 개시 | Morgan Stanley | Overweight |
| 2020-11-23 | 개시 | William Blair | Outperform |
바이오데식스 주식(BDSX)의 최신 뉴스
Biodesix, Inc. (NASDAQ:BDSX) Q3 2024 Earnings Call Transcript - MSN
Earnings call: Biodesix sees strong growth in Q3 with $18.2M revenue - Investing.com India
Brokerages Set Biodesix, Inc. (NASDAQ:BDSX) PT at $3.06 - MarketBeat
Biodesix, Inc. (NASDAQ:BDSX) Receives Consensus Rating of “Buy” from Analysts - Defense World
Biodesix (NASDAQ:BDSX) Issues Earnings Results, Beats Expectations By $0.01 EPS - MarketBeat
Biodesix reports Q3 EPS (7c), consensus (7c) - MSN
Biodesix Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
Biodesix Inc (BDSX) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Operational ... - Yahoo Finance UK
Biodesix Inc (BDSX) Q3 2024 Earnings Call Highlights: Strong Rev - GuruFocus.com
Biodesix Reports Strong Q3 2024 Growth in Diagnostics - TipRanks
Biodesix trims losses but misses Wall Street sales projection - BizWest
Biodesix Announces Third Quarter 2024 Results and Highlights - GlobeNewswire
Biodesix, Inc. (BDSX) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Finance
Biodesix Inc (BDSX) Q3 2024 Earnings: Revenue at $18.2M, EPS Mat - GuruFocus.com
Biodesix, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Biodesix, Inc. Reiterates Revenue Guidance for the Fiscal Year 2024-25 - Marketscreener.com
What To Expect From Biodesix Inc (BDSX) Q3 2024 Earnings - Yahoo Finance
With 47% ownership, Biodesix, Inc. (NASDAQ:BDSX) insiders have a lot riding on the company's future - Yahoo Finance
Biodesix to Participate in Three Investor Conferences in November - The Manila Times
Scotiabank Initiates Coverage of Biodesix (BDSX) with Sector Outperform Recommendation - MSN
Biodesix (BDSX) Set to Announce Quarterly Earnings on Friday - Defense World
Biodesix (BDSX) Scheduled to Post Earnings on Friday - MarketBeat
Biodesix to Report Third Quarter 2024 Financial Results on November 1, 2024 - Business Wire
Short Interest in Biodesix, Inc. (NASDAQ:BDSX) Rises By 29.3% - MarketBeat
Biodesix, Inc. (NASDAQ:BDSX) Given Average Recommendation of "Buy" by Brokerages - MarketBeat
Biodesix Announces New Data Presentation at CHEST 2024 Annual Meeting and the Launch of a Complementary Clinical Study - BioSpace
Perceptive Advisors LLC Takes $3.33 Million Position in Biodesix, Inc. (NASDAQ:BDSX) - Defense World
2,173,880 Shares in Biodesix, Inc. (NASDAQ:BDSX) Bought by Perceptive Advisors LLC - MarketBeat
Biodesix, Inc. (NASDAQ:BDSX) Short Interest Down 9.2% in September - MarketBeat
CVI Holdings LLC Makes New Investment in Biodesix, Inc. (NASDAQ:BDSX) - Defense World
Biodesix Inc (BDSX) Stock: A Year of Stock Market Ups and Downs - The InvestChronicle
Farallon Capital Management LLC Purchases New Stake in Biodesix, Inc. (NASDAQ:BDSX) - Defense World
Trading Day Triumph: Biodesix Inc (BDSX) Ends at 1.59, a -11.67 Surge/Plunge - The Dwinnex
Farallon Capital Management LLC Takes Position in Biodesix, Inc. (NASDAQ:BDSX) - MarketBeat
Does Biodesix (NASDAQ:BDSX) Have A Healthy Balance Sheet? - Simply Wall St
Biodesix Inc (BDSX) expanding its growth trajectory ahead - SETE News
Biohaven surges as genetic disease drug meets main study goal By Reuters - Investing.com
Sartorius Stedim Biotech S.A. (EPA:DIM) On An Uptrend: Could Fundamentals Be Driving The Stock? - Simply Wall St
Market Watch Highlights: Biodexa Pharmaceuticals Plc ADR (BDRX) Ends on an Downturn Note at 0.29 - The Dwinnex
Inspire Investing LLC Has $353,000 Stake in Brandywine Realty Trust (NYSE:BDN) - Defense World
Brandywine Realty Trust (BDN) Performance and Fundamentals Dashboard tells a completely different story - SETE News
BCDA’s Stochastic Averages Dip: Analyzing BioCardia Inc.’s Stock Performance - The InvestChronicle
Biodesix, Inc. (NASDAQ:BDSX) Sees Significant Decrease in Short Interest - Defense World
BD launches new prefillable syringe, expands platform capacity - Drug Delivery Business News
Biodesix (NASDAQ:BDSX) Coverage Initiated at Scotiabank - Defense World
Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) Short Interest Update - Defense World
Sartorius Stedim Biotech (EPA:DIM) Shares Down 1.3% - Defense World
Despite lower earnings than five years ago, Boyd Group Services (TSE:BYD) investors are up 19% since then - Simply Wall St
Boyd Group Services Announces Q3 Cash Dividend - TipRanks
Biodesix (NASDAQ:BDSX) Now Covered by Scotiabank - MarketBeat
Biodesix initiated with an Outperform at Scotiabank - TipRanks
바이오데식스 (BDSX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.48%
0.04%
자본화:
|
볼륨(24시간):